HC Wainwright Issues Optimistic Estimate for RYTM Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Investment analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Rhythm Pharmaceuticals in a report released on Monday, March 3rd. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.68) per share for the quarter, up from their previous estimate […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Investment analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Rhythm Pharmaceuticals in a report released on Monday, March 3rd. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.68) per share for the quarter, up from their previous estimate […]
